Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1985;7:533-540

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomanek, R. J.
Right arrow Articles by Bauer, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomanek, R. J.
Right arrow Articles by Bauer, C. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*HYDRALAZINE HYDROCHLORIDE

Hypertension, Vol 7, 533-540, Copyright © 1985 by American Heart Association


ARTICLES

Prevention of coronary vasodilator reserve decrement in spontaneously hypertensive rats

RJ Tomanek, RD Wangler and CA Bauer

Spontaneously hypertensive rats (SHR) demonstrate an elevated minimal coronary vascular resistance by the seventh month of age. In an attempt to determine the role of long-standing hypertension in the etiological process of the elevated minimal coronary vascular resistance, we treated SHR and normotensive Wistar-Kyoto rats (WKY) with the vasodilator hydralazine from the time of weaning (1 month) until they were 7 to 8 months of age. The animals were instrumented 24 hours after their last drug dose and then studied on the following day. Using microspheres we measured myocardial perfusion in conscious rats at rest and during maximal coronary dilation induced with dipyridamole infusion. Hydralazine maintained arterial blood pressures in the normotensive range throughout the experimental period, but had little effect on left ventricular weight/body weight ratios (control SHR = 2.95 +/- 0.07, treated SHR = 2.73 +/- 0.08, control WKY = 2.39 +/- 0.09, mean +/- SEM). In treated SHR, left ventricular minimal coronary vascular resistance (per 100 g of tissue) was markedly lower (0.10 +/- 0.01) than in the controls (0.16 +/- 0.01) and not significantly different from that of WKY (0.11 +/- 0.01). Similar differences were noted in the nonhypertrophic right ventricle (treated SHR = 0.08 +/- 0.01, control SHR = 0.16 +/- 0.01, control WKY = 0.10 +/- 0.01). Total minimal coronary vascular resistance was also lower in both ventricles of the treated SHR compared with their nontreated controls. In WKY, hydralazine treatment significantly reduced blood pressure and total minimal coronary vascular resistance (p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. S. Choy and G. S. Kassab
Wall thickness of coronary vessels varies transmurally in the LV but not the RV: implications for local stress distribution
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H750 - H758.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. C. Poirier, J.-H. Yu, C. P. Brizard, and R. B. B. Mee
Long-term results of left ventricular reconditioning and anatomic correction for systemic right ventricular dysfunction after atrial switch procedures
J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 975 - 981.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Morisco, J. Sadoshima, B. Trimarco, R. Arora, D. E. Vatner, and S. F. Vatner
Is treating cardiac hypertrophy salutary or detrimental: the two faces of Janus
Am J Physiol Heart Circ Physiol, April 1, 2003; 284 (4): H1043 - H1047.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
J. Varagic, D. Susic, and E. D. Frohlich
Cardiovasc Pharmacol Therapeut 6(1):57-63, 2001 Low-Dose ACE with Alphaor Beta-Adrenergic Receptor Inhibitors Have Beneficial SHR Cardiovascular Effects
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2001; 6(1): 57 - 63.
[Abstract] [PDF]


Home page
HypertensionHome page
D. Susic, A. Francischetti, and E. D. Frohlich
Prolonged L-Arginine on Cardiovascular Mass and Myocardial Hemodynamics and Collagen in Aged Spontaneously Hypertensive Rats and Normal Rats
Hypertension, January 1, 1999; 33(1): 451 - 455.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Duncker, Y. Ishibashi, and R. J. Bache
Effect of treadmill exercise on transmural distribution of blood flow in hypertrophied left ventricle
Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1274 - H1282.
[Abstract] [Full Text] [PDF]